Revolution Medicines (RVMD) EBITDA Margin (QoQ) (2019 - 2023)
Revolution Medicines (RVMD) EBITDA Margin (QoQ) (2019 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -177,358.00 |
| Mar 31, 2023 | -66,900.00 |
| Dec 31, 2022 | 187,796.00 |
| Sep 30, 2022 | -159,938.00 |
| Jun 30, 2022 | 8,360.00 |
| Mar 31, 2022 | -20,537.00 |
| Dec 31, 2021 | 426,928.00 |
| Sep 30, 2021 | -431,660.00 |
| Jun 30, 2021 | -14,288.00 |
| Mar 31, 2021 | 2,031.00 |
| Dec 31, 2020 | -17,184.00 |
| Sep 30, 2020 | 6,154.00 |
| Jun 30, 2020 | -9,655.00 |
| Mar 31, 2020 | -2,074.00 |
| Dec 31, 2019 | -5,343.00 |
| Sep 30, 2019 | -2,243.00 |
| Jun 30, 2019 | -673.00 |